| Literature DB >> 24124573 |
Biju Sam Kamalam1, Françoise Médale, Laurence Larroquet, Geneviève Corraze, Stephane Panserat.
Abstract
The present study investigated the effect of dietary carbohydrates on metabolism, with special focus on fatty acid bioconversion and flesh lipid composition in two rainbow trout lines divergently selected for muscle lipid content and fed with vegetable oils. These lines were chosen based on previously demonstrated potential differences in LC-PUFA synthesis and carbohydrate utilization. Applying a factorial study design, juvenile trout from the lean (L) and the fat (F) line were fed vegetable oil based diets with or without gelatinised starch (17.1%) for 12 weeks. Blood, liver, muscle, intestine and adipose tissue were sampled after the last meal. Feed intake and growth was higher in the L line than the F line, irrespective of the diet. Moderate postprandial hyperglycemia, strong induction of hepatic glucokinase and repressed glucose-6-phosphatase transcripts confirmed the metabolic response of both lines to carbohydrate intake. Further at the transcriptional level, dietary carbohydrate in the presence of n-3 LC-PUFA deficient vegetable oils enhanced intestinal chylomicron assembly, disturbed hepatic lipid metabolism and importantly elicited a higher response of key desaturase and elongase enzymes in the liver and intestine that endorsed our hypothesis. PPARγ was identified as the factor mediating this dietary regulation of fatty acid bioconversion enzymes in the liver. However, these molecular changes were not sufficient to modify the fatty acid composition of muscle or liver. Concerning the genotype effect, there was no evidence of substantial genotypic difference in lipid metabolism, LC-PUFA synthesis and flesh fatty acid profile when fed with vegetable oils. The minor reduction in plasma glucose and triglyceride levels in the F line was linked to potentially higher glucose and lipid uptake in the muscle. Overall, these data emphasize the importance of dietary macro-nutrient interface in evolving fish nutrition strategies.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24124573 PMCID: PMC3790683 DOI: 10.1371/journal.pone.0076570
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Composition of diets.
| VOC- | VOC+ | |
|
| ||
| Fish meal | 60 | 60 |
| Wheat gluten | 20 | 0 |
| Gelatinized starch | 0 | 20 |
| Vegetable oil mix | 18 | 18 |
| Mineral mix | 1 | 1 |
| Vitamin mix | 1 | 1 |
|
| ||
| Dry matter, % | 94.0 | 94.4 |
| Protein, % DM | 58.6 | 43.0 |
| Lipid, % DM | 25.4 | 25.7 |
| Starch, % DM | 1.8 | 17.1 |
| Energy, kJ/g DM | 24.9 | 24.4 |
| Ash, % DM | 9.3 | 8.6 |
VOC-, diet without carbohydrate; VOC+, diet with carbohydrate; DM, dry matter.
Sopropeche, Boulogne-sur-Mer, France
Roquette, Lestrem, France
Linseed/Palm/Rapeseed oil in the ratio 50∶30∶20 (Daudruy, Dunkerque, France)
Supplied the following (kg−1 diet): calcium carbonate (40% Ca) 2.15 g, magnesium oxide (60% Mg) 1.24 g, ferric citrate 0.2 g, potassium iodide (75% I) 0.4 mg, zinc sulphate (36% Zn) 0.4 g, copper sulphate (25% Cu) 0.3 g, manganese sulphate (33% Mn) 0.3 g, dibasic calcium phosphate (20% Ca, 18% P) 5 g, cobalt sulphate 2 mg, sodium selenite (30% Se) 3 mg, potassium chloride 0.9 g, Sodium chloride 0.4 g.
Supplied the following (kg−1 diet): DL-a tocopherol acetate 60 IU, sodium menadione bisulphate 5 mg, retinyl acetate 15000 IU, DLcholecalciferol 3000 IU, thiamin 15 mg, riboflavin 30 mg, pyridoxine 15 mg, vit. B12 0.05 mg, nicotinic acid 175 mg, folic acid 500 mg, inositol 1000 mg, biotin 2.5 mg, calcium panthotenate 50 mg, choline chloride 2000 mg.
Primer sequences.
| Gene | Foward primer (5′ - 3′) | Reverse primer (5′ - 3′) | Database and Accession No. | Annealing Temperature, oC | Amplicon size, bp |
| 18 S |
|
| GenBank AF308735 | 56 | 62 |
| SGLT1 |
|
| GenBank AY210436 | 59 | 154 |
| GLUT2 |
|
| GenBank AF321816 | 59 | 227 |
| MTP |
|
| GenBank BX860503 | 55 | 152 |
| ApoB |
|
| GenBank CA383905 | 55 | 196 |
| ApoA1 |
|
| GenBank AF042218 | 59 | 115 |
| ApoA4 |
|
| GenBank CA363690 | 55 | 148 |
| GK |
|
| GenBank AF135403 | 59 | 253 |
| HK1 |
|
| GenBank AY864082 | 59 | 159 |
| G6Pase1 |
|
| Sigenae tcay0019b.d.18_3.1.s.om.8 | 55 | 77 |
| G6Pase2 |
|
| GenBank AF120150 | 55 | 82 |
| G6PD |
|
| GenBank CA351434 | 59 | 176 |
| ACLY |
|
| GenBank CA349411.1 | 60 | 149 |
| ACC |
|
| Sigenae tcbk0010c.b.21_5.1.om.4 | 55 | 152 |
| FAS |
|
| Sigenae tcab0001c.e.06_5.1.s.om.8 | 60 | 161 |
| D9D |
|
| GenBank FP323026 | 60 | 204 |
| SREBP1c |
|
| GenBank CA048941.1 | 60 | 59 |
| D6D |
|
| Genbank AF301910 | 59 | 175 |
| Elovl2 |
|
| Sigenae FYV3OTN01A4WMI.s.om.10 | 59 | 146 |
| Elovl5 |
|
| Genbank AY605100 | 59 | 149 |
| CPT1a |
|
| GenBank AF327058 | 55 | 166 |
| CPT1b |
|
| GenBank AJ606076 | 55 | 149 |
| CPT1c |
|
| GenBank AJ619768 | 59 | 187 |
| CPT1d |
|
| GenBank AJ620356 | 59 | 154 |
| PPARα |
|
| GenBank AY494835 | 54 | 195 |
| PPARβ |
|
| GenBank AY356399 | 60 | 195 |
| PPARγ |
|
| Genbank CA345564 | 60 | 171 |
| GLUT4 |
|
| GenBank AF247395 | 60 | 207 |
| LPL |
|
| GenBank AJ224693 | 59 | 164 |
| VLDLR |
|
| GenBank BX077158 | 60 | 160 |
| CD36 |
|
| GenBank BX300637 | 60 | 121 |
Sánchez-Gurmaches et al. [69]
Feed intake, morphological indices and tissue lipid content.
| VOC- | VOC+ |
| |||||
| Fat | Lean | Fat | Lean | Diet | Line | D*L | |
| Feed intake, g/kg/day | 12.9±0.2 | 13.2±0.2 | 12.5±0.4 | 13.2±0.3 | 0.32 | 0.02 | 0.29 |
| Final body weight, g | 216.7±28.4 | 268.9±6.0 | 210.1±12.6 | 269.4±3.1 | 0.74 | 3×10−4 | 0.71 |
| Hepato-somatic index, % | 1.5±0.3 | 1.4±0.2 | 1.7±0.2 | 1.6±0.3 | 2×10−4 | 0.03 | 0.58 |
| Viscero-somatic index, % | 11.5±2.0 | 11.8±3.0 | 12.3±1.8 | 13.4±1.1 | 0.006 | 0.15 | 0.35 |
| Muscle lipid, % | 7.9±1.2 | 4.2±0.8 | 8.2±1.2 | 4.7±0.8 | 0.37 | <10−4 | 0.83 |
| Liver lipid, % | 5.3±0.3a | 5.2±0.3a | 5.1±0.5a | 4.5±0.2b | 2×10−4 | 0.001 | 0.02 |
The data are represented as means ± s.d. (N = 3 tanks for feed intake and body weight estimation; N = 9 individuals for morphological indices estimation; N = 6 individuals for tissue lipid analysis) and were analysed by two-way ANOVA (P<0.05) followed by Student–Newman–Keuls multiple comparison test.
Postprandial plasma metabolites.
| Plasma metabolites | VOC- | VOC+ |
| |||||
| Fat | Lean | Fat | Lean | Diet | Line | D*L | ||
| Glucose (mmol/L) | 2 h | 4.4±0.7 | 4.7±0.6 | 5.9±0.9 | 5.7±1.1 | <10−4 | 0.95 | 0.41 |
| 8 h | 5.1±0.8 | 5.3±0.8 | 5.7±1.0 | 7.5±2.4 | 0.006 | 0.05 | 0.09 | |
| Triglycerides (mmol/L) | 2 h | 1.2±0.7 a | 1.0±0.5 a | 1.6±0.9 | 1.5±0.9 a | 0.12 | 0.54 | 0.82 |
| 8 h | 2.2±1.2 b | 3.2±1.7 b | 2.0±1.3 | 3.6±1.5 b | 0.83 | 0.01 | 0.61 | |
| Cholesterol (mmol/L) | 2 h | 4.2±1.1 | 4.5±0.5 | 5.0±1.1 | 5.7±1.3 | 0.005 | 0.13 | 0.47 |
| 8 h | 4.4±1.2 | 4.9±1.6 | 5.0±1.5 | 5.2±1.3 | 0.33 | 0.43 | 0.81 | |
| Free amino acids (mg Eq. Glycine/ml) | 2 h | 0.5±0.1 | 0.5±0.06 | 0.5±0.08 b | 0.44±0.06 b | 0.08 | 0.24 | 0.74 |
| 8 h | 0.5±0.1 | 0.5±0.07 | 0.4±0.04 a | 0.36±0.08 a | 0.003 | 0.19 | 0.70 | |
Data are presented as means ± s.d. (N = 9 individuals). At each postprandial time, the effect of diet, line and interaction were analysed by two-way ANOVA (P<0.05) followed by Student–Newman–Keuls multiple comparison test. Within each dietary treatment (column wise), significant differences in postprandial kinetics (2 h, 8 h after the last meal) are represented with different superscripts a,b (one-way ANOVA, P<0.05).
Figure 1Gene expression of intestinal membrane glucose transporters and proteins involved in chylomicron assembly.
mRNA levels of sodium-dependent glucose co-transporter type 1 (SGLT1), glucose facilitative transporter type 2 (GLUT2), microsomal triglyceride transfer protein (MTP), apolipoprotein B (ApoB), apolipoprotein A1 (ApoA1) and apolipoprotein A4 (ApoA4) were measured using real-time quantitative RT-PCR in the intestine of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC-) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Figure 2Gene expression of selected glycolytic and gluconeogenic enzymes.
mRNA levels of glucokinase (GK), glucose-6-phosphatase isoform 1 (G6Pase1), isoform 2 (G6Pase2) and hexokinase (HK) were measured using real-time quantitative RT-PCR in the liver (row A); muscle (B), adipose tissue (C) and intestine (D) of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Figure 3Gene expression of selected enzymes and transcription factor involved in NADPH generation and lipogenesis.
mRNA levels of glucose 6-phosphate dehydrogenase (G6PD), ATP citrate lyase (ACLY), acetyl coA carboxylase (ACC), fatty acid synthase (FAS), 9 fatty acyl desaturase (D9D) and sterol regulatory element binding protein 1-like (SREBP-1c) were measured using real-time quantitative RT-PCR in the liver (A - two rows) and adipose tissue (B - two rows) of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Figure 4Gene expression of selected enzymes involved in fatty acid bioconversion.
mRNA levels of 6 fatty acyl desaturase (D6D), elongation of very long chain fatty acids like-2 (Elovl2) and elongation of very long chain fatty acids like-5 (Elovl5) were measured using real-time quantitative RT-PCR in the liver (row A) and intestine (row B) of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Figure 5Gene expression of carnitine palmitoyl transferase (CPT1) isoforms involved in fatty acid oxidation.
mRNA levels of CPT1a, CPT1b, CPT1c and CPT1d were measured using real-time quantitative RT-PCR in the liver (column A), muscle (column B) and adipose tissue (column C) of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA (P<0.05) followed by Student–Newman–Keuls test for multiple comparison. When interactions were significant, means were compared using one way ANOVA (P<0.05).
Figure 6Gene expression of peroxisome proliferator activated receptor isoforms.
mRNA levels of PPARα, PPARβ and PPARγ were measured using real-time quantitative RT-PCR in the liver (row A), intestine (row B), adipose tissue (row C) and muscle (row D) of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Figure 7Gene expression of selected proteins involved in glucose and lipid uptake in the white muscle.
mRNA levels of glucose facilitative transporter type 4 (GLUT4), lipoprotein lipase (LPL), very low density lipoprotein receptor (VLDLR) and fatty acid translocase (CD36) were measured using real-time quantitative RT-PCR in the muscle of rainbow trout from a fat line (F; black bar) and a lean line (L; grey bar) fed a diet without (VOC−) or with (VOC+) carbohydrate, 8 h after the last meal. Expression values are normalized by 18 S ribosomal RNA (18 S) expressed transcripts. Relative fold difference between treatments are presented as means + s.d. (N = 6 individuals) and were analyzed using two-way ANOVA followed by Student–Newman–Keuls test for multiple comparison. Differences were considered significant at P<0.05
Fatty acid profile of diets expressed as % of total fatty acids.
| Fatty acids | VOC− | VOC+ |
| SFA | ||
| 14∶0 | 1.4 | 0.8 |
| 16∶0 | 15.5 | 14.8 |
| 17∶0 | 0.1 | 0.1 |
| 18∶0 | 3.0 | 3.3 |
| 20∶0 | 0.3 | 0.3 |
| ∑SFA | 20.4 | 19.5 |
| MUFA | ||
| 16∶1 | 1.1 | 0.6 |
| 18∶1 | 28.1 | 31.7 |
| 20∶1 | 2.5 | 1.8 |
| 22∶1 | 3.2 | 2.2 |
| ∑MUFA | 34.9 | 36.4 |
| n-6 PUFA | ||
| 18∶2 n-6 | 13.9 | 13.0 |
| 20∶2 n-6 | 0.1 | 0.1 |
| 20∶4 n-6 | 0.1 | 0.1 |
| ∑n-6 PUFA | 14.1 | 13.1 |
| n-3 PUFA | ||
| 18∶3 n-3 | 23.4 | 25.8 |
| 18∶4 n-3 | 0.4 | 0.3 |
| 20∶3 n-3 | 0.1 | 0.05 |
| 20∶4 n-3 | 0.1 | 0.1 |
| 20∶5 n-3 | 1.4 | 0.9 |
| 22∶5 n-3 | 0.1 | 0.1 |
| 22∶6 n-3 | 2.9 | 1.9 |
| ∑n-3 PUFA | 28.5 | 29.1 |
| Ratios | ||
| SFA/PUFA | 0.5 | 0.5 |
| n3/n6 | 2.0 | 2.2 |
Fatty acid profile of muscle expressed as % of total fatty acids.
| Fatty acids | VOC− | VOC+ |
| ||||
| Fat | Lean | Fat | Lean | Diet | Line | Diet*Line | |
| SFA | |||||||
| 14∶0 | 1.72±0.38 | 1.37±0.26 | 1.67±0.27 | 1.39±0.20 | 0.92 | 0.01 | 0.80 |
| 16∶0 | 12.32±1.37 | 12.69±1.33 | 11.91±0.74 | 12.32±0.46 | 0.37 | 0.37 | 0.97 |
| 17∶0 | 0.13±0.01 | 0.11±0.01 | 0.11±0.01 | 0.11±0.01 | 0.01 | 0.02 | 0.16 |
| 18∶0 | 2.97±0.30 | 3.23±0.13 | 2.90±0.22 | 3.11±0.22 | 0.33 | 0.02 | 0.77 |
| 20∶0 | 0.17±0.02 | 0.17±0.02 | 0.19±0.03 | 0.17±0.01 | 0.10 | 0.18 | 0.28 |
| ∑SFA | 17.49±1.61 | 17.74±1.59 | 16.96±0.82 | 17.26±0.53 | 0.33 | 0.59 | 0.96 |
| MUFA | |||||||
| 16∶1 | 2.29±0.43 | 1.65±0.35 | 2.25±0.27 | 1.70±0.24 | 0.97 | 3×10−4 | 0.73 |
| 18∶1 | 29.99±0.7 b | 27.50±0.9 a | 30.45±0.9 b | 29.44±1.1 b | 0.003 | <10−4 | 0.05 |
| 20∶1 | 2.75±0.17 | 2.64±0.32 | 2.73±0.33 | 2.55±0.08 | 0.58 | 0.18 | 0.72 |
| 22∶1 | 2.31±0.36 | 2.40±0.39 | 2.56±0.43 | 2.32±0.21 | 0.56 | 0.64 | 0.27 |
| ∑MUFA | 37.33±0.65 | 34.19±1.41 | 37.99±0.62 | 36.01±1.35 | 0.01 | <10−4 | 0.20 |
| n-6 PUFA | |||||||
| 18∶2 n-6 | 12.49±0.61 | 12.01±0.39 | 11.19±0.60 | 11.05±0.52 | <10−4 | 0.17 | 0.45 |
| 18∶3 n-6 | 0.23±0.04 | 0.23±0.03 | 0.19±0.03 | 0.19±0.03 | 0.01 | 0.91 | 0.99 |
| 20∶2 n-6 | 0.63±0.05 | 0.64±0.11 | 0.53±0.09 | 0.51±0.05 | 0.003 | 0.96 | 0.67 |
| 20∶3 n-6 | 0.30±0.02 a | 0.36±0.06 b | 0.28±0.04 a | 0.27±0.02 a | 9×10−4 | 0.06 | 0.03 |
| 20∶4 n-6 | 0.35±0.03 | 0.40±0.02 | 0.33±0.04 | 0.37±0.04 | 0.04 | 0.002 | 0.72 |
| ∑n-6 PUFA | 14.04±0.62 | 13.72±0.33 | 12.61±0.53 | 12.39±0.51 | <10−4 | 0.21 | 0.81 |
| n-3 PUFA | |||||||
| 18∶3 n-3 | 13.07±0.47 | 14.07±0.32 | 14.02±1.02 | 15.22±0.56 | 8×10−4 | 5×10−4 | 0.72 |
| 18∶4 n-3 | 1.40±0.13 | 1.45±0.11 | 1.44±0.24 | 1.45±0.22 | 0.81 | 0.67 | 0.80 |
| 20∶3 n-3 | 0.79±0.11 | 0.89±0.17 | 0.85±0.16 | 0.82±0.11 | 0.91 | 0.51 | 0.29 |
| 20∶4 n-3 | 1.00±0.16 | 1.15±0.27 | 1.13±0.18 | 0.92±0.08 | 0.49 | 0.75 | 0.03 |
| 20∶5 n-3 | 2.43±0.32 | 2.34±0.18 | 2.30±0.41 | 2.39±0.15 | 0.73 | 0.97 | 0.45 |
| 22∶5 n-3 | 1.05±0.25 | 0.89±0.07 | 1.12±0.24 | 0.97±0.06 | 0.31 | 0.04 | 0.99 |
| 22∶6 n-3 | 8.47±0.92 | 10.94±1.33 | 8.75±1.13 | 9.94±1.47 | 0.48 | 0.002 | 0.22 |
| ∑n-3 PUFA | 28.48±1.25 | 32.00±1.64 | 29.89±0.80 | 31.80±1.16 | 0.25 | <10−4 | 0.13 |
| Ratios | |||||||
| SFA/PUFA | 0.41±0.05 | 0.39±0.04 | 0.39±0.02 | 0.39±0.01 | 0.72 | 0.33 | 0.63 |
| n3/n6 | 2.03±0.11 | 2.33±0.14 | 2.38±0.15 | 2.57±0.19 | 10−4 | 5×10−4 | 0.39 |
The data are presented as means ± s.d. (N = 6 individuals) and were analysed by two-way ANOVA (P<0.05) followed by Student–Newman–Keuls multiple comparison test. a,b Mean values not sharing a common letter are significantly different from each other (one way ANOVA, P<0.05).
Fatty acid content of muscle expressed as mg/g of muscle (wet weight).
| Fatty acids | VOC− | VOC+ |
| ||||
| Fat | Lean | Fat | Lean | Diet | Line | Diet*Line | |
| SFA | 14.0±3.3 | 7.4±1.1 | 13.8±1.5 | 8.0±1.3 | 0.77 | <10−4 | 0.64 |
| MUFA | 29.6±4.9 | 14.3±2.8 | 31.1±4.9 | 16.8±3.6 | 0.24 | <10−4 | 0.77 |
| n-6 PUFA | 11.1±1.5 | 5.7±1.1 | 10.3±1.2 | 5.8±1.2 | 0.49 | <10−4 | 0.41 |
| 20∶5 n-3 | 1.9±0.2 | 1.0±0.2 | 1.9±0.5 | 1.1±0.2 | 0.60 | <10−4 | 0.62 |
| 22∶6 n-3 | 6.6±0.7 | 4.6±1.1 | 7.2±1.9 | 4.5±0.4 | 0.56 | <10−4 | 0.50 |
| n-3 PUFA | 22.4±2.5 | 13.4±2.7 | 24.5±4.2 | 14.7±2.1 | 0.17 | <10−4 | 0.76 |
| n3/n6 | 2.03±0.11 | 2.33±0.14 | 2.38±0.15 | 2.57±0.19 | 10−4 | 5×10−4 | 0.39 |
The data are presented as means ± s.d. (N = 6 individuals) and were analysed by two-way ANOVA followed by Student–Newman–Keuls multiple comparison test. Differences were considered statistically significant at P<0.05
Fatty acid profile of liver expressed as % of total fatty acids.
| Fatty acids | VOC− | VOC+ |
| ||||
| Fat | Lean | Fat | Lean | Diet | Line | Diet*Line | |
| SFA | |||||||
| 14∶0 | 0.62±0.16 | 0.41±0.10 | 0.61±0.08 | 0.56±0.08 | 0.14 | 0.01 | 0.08 |
| 16∶0 | 16.39±1.54 | 14.31±2.22 | 14.83±1.89 | 15.15±1.70 | 0.64 | 0.25 | 0.12 |
| 17∶0 | 0.13±0.02 | 0.13±0.01 | 0.11±0.02 | 0.12±0.01 | 0.21 | 0.44 | 0.35 |
| 18∶0 | 6.67±0.92 | 6.63±0.31 | 6.54±0.84 | 6.52±0.47 | 0.67 | 0.91 | 0.96 |
| 20∶0 | 0.15±0.01 | 0.19±0.03 | 0.16±0.04 | 0.17±0.02 | 0.51 | 0.04 | 0.17 |
| ∑SFA | 24.07±1.22 | 21.76±2.27 | 22.33±1.54 | 22.63±1.51 | 0.52 | 0.15 | 0.07 |
| MUFA | |||||||
| 16∶1 | 0.82±0.17 | 0.60±0.15 | 0.80±0.28 | 0.74±0.13 | 0.47 | 0.08 | 0.31 |
| 18∶1 | 14.36±1.50 | 13.17±0.66 | 14.25±2.10 | 14.19±1.18 | 0.45 | 0.31 | 0.36 |
| 20∶1 | 1.78±0.80 | 1.68±0.45 | 1.79±0.66 | 1.74±0.35 | 0.89 | 0.76 | 0.91 |
| 22∶1 | 0.56±0.32 | 0.60±0.18 | 0.70±0.18 | 0.77±0.63 | 0.31 | 0.73 | 0.93 |
| ∑MUFA | 17.52±2.15 | 16.04±0.78 | 17.54±2.23 | 17.43±1.27 | 0.32 | 0.27 | 0.34 |
| n-6 PUFA | |||||||
| 18∶2 n-6 | 5.53±0.84 | 5.57±0.27 | 4.90±0.74 | 5.04±0.55 | 0.03 | 0.74 | 0.87 |
| 18∶3 n-6 | 0.21±0.09 | 0.23±0.04 | 0.13±0.03 | 0.16±0.04 | 0.003 | 0.19 | 0.81 |
| 20∶2 n-6 | 1.03±0.54 | 0.97±0.32 | 0.87±0.29 | 0.89±0.21 | 0.41 | 0.88 | 0.76 |
| 20∶3 n-6 | 1.17±0.24 | 1.31±0.30 | 1.28±0.36 | 1.00±0.16 | 0.39 | 0.55 | 0.08 |
| 20∶4 n-6 | 2.25±0.19 | 2.58±0.54 | 1.85±0.16 | 2.49±0.29 | 0.08 | 0.001 | 0.26 |
| 22∶2 n-6 | 0.08±0.05 | 0.09±0.03 | 0.10±0.03 | 0.10±0.02 | 0.20 | 0.86 | 0.52 |
| ∑n-6 PUFA | 10.26±0.46 | 10.74±0.26 | 9.14±0.77 | 9.67±0.27 | <10−4 | 0.02 | 0.89 |
| n-3 PUFA | |||||||
| 18∶3 n-3 | 4.00±0.61 | 3.85±0.53 | 4.56±0.87 | 4.47±0.85 | 0.06 | 0.68 | 0.93 |
| 18∶4 n-3 | 0.93±0.69 | 0.78±0.24 | 0.74±0.31 | 0.80±0.33 | 0.61 | 0.78 | 0.56 |
| 20∶3 n-3 | 0.88±0.41 | 0.82±0.26 | 0.92±0.23 | 0.85±0.22 | 0.74 | 0.58 | 0.93 |
| 20∶4 n-3 | 0.89±0.35ab | 1.0±0.46ab | 1.41±0.47a | 0.72±0.15b | 0.45 | 0.08 | 0.02 |
| 20∶5 n-3 | 4.78±1.11 | 4.95±0.81 | 3.83±0.53 | 4.86±0.75 | 0.13 | 0.08 | 0.20 |
| 22∶5 n-3 | 0.87±0.46 | 1.14±0.19 | 1.31±0.36 | 1.46±0.38 | 0.02 | 0.16 | 0.68 |
| 22∶6 n-3 | 28.88±1.68 | 33.65±3.35 | 32.52±4.11 | 32.07±2.71 | 0.42 | 0.10 | 0.05 |
| ∑n-3 PUFA | 41.2±2.4b | 46.2±3.36a | 45.3±3.3ab | 45.2±2.5a | 0.20 | <0.05 | 0.04 |
| Ratios | |||||||
| SFA/PUFA | 0.47±0.04a | 0.38±0.06b | 0.4±0.04ab | 0.4±0.04ab | 0.48 | <0.05 | 0.04 |
| n3/n6 | 4.02±0.26 | 4.30±0.30 | 5.01±0.78 | 4.68±0.33 | 0.002 | 0.89 | 0.13 |
The data are presented as means ± s.d. (N = 6 individuals) and were analysed by two-way ANOVA (P<0.05) followed by Student–Newman–Keuls multiple comparison test. a,b Mean values not sharing a common letter are significantly different from each other (one way ANOVA, P<0.05).